GI Innovation Inc

KRX • Healthcare • Biotechnology • Quote as of 10/28/2026 15:30

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeKRX

Market Capitalization453,548 mln

Float56.78 mln

Piotroski F-Score

6 / 9

Solid

Beneish M-Score

2.51

Highly suspicious

Relative Strength

27 / 100

Underperforming

Debt / Equity

0.02

Debt-free

Pre-Tax Margin

-699%

Severely loss-making

ROE

-34.48

Deeply negative

Key Fundamentals

EPS-614

ROE-34.48

ROIC-53.87

ROA-31.25

EBITDA, mln-35,468

EV / EBITDA-13.36

EV / EBIT-12.54

Revenue, mln5,500

EV / Revenue86.12

Quote Details

Last 7,140.00

Change 110 (1.56%)

Open 7,040.00

Volume 177,958

Turnover 1,270,620,160

Average Volume 276,740

Financial Ratios

Pre-Tax Profit Margin-699

Current Ratio6.18

Price / Book5.31

Price / Tangible Book5.40

Debt / Equity0.02

Price / Sales92.31

Financial Strength

Altman Z-Score29.25

Piotroski F-Score 6 / 9

Beneish M-Score2.51

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-11.41%	4 / 100
1 Month	-19.5%	10 / 100
2 Months	-2.46%	56 / 100
6 Months	-51.36%	12 / 100
1 Year	-58.27%	7 / 100